Company Website

Contact Information:

Courtney Boroff
Cboroff@its.jnj.com
904-465-1973

                                                                                                                                                                                                                                                                                  Virtual Exhibit Hall Home

Monovisc, Orthovisc & PEAK PRP
MONOVISC® High Molecular Weight Hyaluronan is an FDA approved treatment made from ultra-pure hyaluronan, a naturally occurring lubricant found in healthy knee joints. MONOVISC® is a non-avian sourced viscosupplement that provides early and durable pain relief in a single high concentration injection that is conveniently packaged in a 4 mL volume for ease of use by physicians and minimum injection discomfort for patients.1

As OA of the knee progresses, prescription medications such as NSAIDs, COX-2 Inhibitors and intraarticular corticosteroid injections may be appropriate next course of therapy choices. Due to contraindications, co-morbidities or adverse events, COX-2 Inhibitors and/or NSAIDs may or may not be an appropriate choice.

These treatments may have provided relief to date but may no longer seem effective due to the disease state progression. A next-step consideration in the Continuum of Care for Knee Osteoarthritis is Hyaluronic Acid (HA) Injections, such as MONOVISC®.

ORTHOVISC® High Molecular Weight Hyaluronan
ORTHOVISC® High Molecular Weight Hyaluronan is a FDA approved treatment made from ultra-pure hyaluronan, a naturally occurring lubricant found in healthy knee joints. ORTHOVISC® Hyaluronan is a non-avian sourced hyaluronic acid injection therapy which has up to six months of clinically proven efficacy with 3 or 4 injections.1

As OA of the knee progresses, prescription medications such as NSAIDs, COX-2 Inhibitors and intraarticular corticosteroid injections may be appropriate next course of therapy choices. Due to contraindications, co-morbidities or adverse events, COX-2 Inhibitors and/or NSAIDs may or may not be an appropriate choice.

These treatments may have provided relief to date but may no longer seem effective due to the disease state progression. A next-step consideration in the Continuum of Care for Knee Osteoarthritis is Hyaluronic Acid Injections, such as ORTHOVISC® Hyaluronan.

PEAK® Platelet Rich Plasma System
DePuy Synthes Mitek Sports Medicine is a leader in developing Early Intervention solutions, providing you with options to treat your patients. The PEAK® Platelet Rich Plasma System represents an option in autologous cellular therapies featuring a vertical roto centrifugation process. The proprietary technology consistently delivers 3 ml of 7.8x high-concentration platelet rich plasma (PRP) from 27 ml of whole blood within 2.5 minutes.

POWER IN SIMPLICITY™
Designed with you and your patients in mind, the PEAK PRP System delivers power in its simple, user-friendly design to achieve consistent and reproducible results.

Additional Information
Science of HA
Monovisc White Paper
PEAK PRP